Infectious Diseases News and Research

RSS

New cell culture model generates the alveolar macrophage in the lab

Researchers at Texas Biomedical Research Institute have succeeded in generating the lung's most important immune cell, the alveolar macrophage, in the lab.

12 Jun 2023

Metformin reduces risk of long COVID by over 40%

Researchers discuss whether metformin, ivermectin, or fluvoxamine could reduce the risk of long COVID if administered shortly after infection.

12 Jun 2023

Rising alcohol consumption in China linked to increased risk of 61 diseases

The associations between alcohol consumption and the risk of diseases in Chinese adults.

12 Jun 2023

Oliver Dowden: New Biothreats Radar will be key to the UK’s fight against future biological threats

A new Biothreats Radar capable of scanning biological risks that pose a threat to the public will be key to the UK's fight and preparation for future pandemics, the Deputy Prime Minister Oliver Dowden has announced today (Monday 12 June).

12 Jun 2023

Common diabetes drug prevents the development of long COVID, study finds

In a new study published in The Lancet Infectious Diseases, University of Minnesota researchers found that metformin, a drug commonly used to treat diabetes, prevents the development of long COVID.

9 Jun 2023

Higher levels of loss aversion among women linked to lower willingness to take risks than men

Women are less willing to take risks than men because they are more sensitive to the pain of any losses they might incur than any gains they might make, new research from the University of Bath School of Management shows.

9 Jun 2023

Study reveals factors impacting pertussis antibody half-lives in infants, sheds light on preterm infants' resilience

Researchers compared two methods of half-life estimation to evaluate the half-life of maternal antibodies.

9 Jun 2023

How did the COVID-19 pandemic impact the fungal infection hospitalization rates?

Researchers examined hospitalizations for fungal infections during the coronavirus disease 2019.

9 Jun 2023

Investigating the alveolar type II reparative response in COVID-19 pneumonia

Researchers investigated the alveolar type II reparative response in COVID-19 pneumonia.

9 Jun 2023

Insilico Medicine nominates pan-TEAD inhibitor as a potential solution for drug resistance in solid tumor patients

Insilico Medicine, a generative artificial intelligence (AI)-driven clinical-stage drug discovery company, today announced the nomination of ISM6331, a potential best-in-class pan-TEAD inhibitor, as a preclinical candidate compound (PCC) generated by Chemistry42, its proprietary generative chemistry-driven molecule design engine, targeting the Hippo pathway for the treatment of advanced solid tumors.

8 Jun 2023

Debt deal leaves health programs (mostly) intact

A final deal cut between President Joe Biden and House Republicans extends the U.S. debt ceiling deadline to 2025 and reins in some spending.

8 Jun 2023

University Hospital Centre for Emerging Viral Diseases named as a WHO collaborating center for epidemic and pandemic diseases

The World Health Organization (WHO), the University of Geneva (UNIGE) and Geneva University Hospitals (HUG), yesterday formalized the designation of the University Hospital Centre for Emerging Viral Diseases as a WHO collaborating center for epidemic and pandemic diseases.

8 Jun 2023

How the mixed messaging of vaccine skeptics sows seeds of doubt

It was a late-spring House of Representatives hearing, where members of Congress and attendees hoped to learn lessons from the pandemic. Witness Marty Makary made a plea.

8 Jun 2023

Global partnership to make UQ a major international hub for vaccine discovery and development

Queensland will become a major international hub for vaccine discovery and development with a global partnership formed in the United States today to help address the world's critical health challenges.

6 Jun 2023

New data from the nationwide INSPIRE study shows Long COVID is not a singular condition

The latest data from the nationwide INSPIRE study assessing the long-term symptoms and outcomes of the COVID-19 virus in nearly 6000 participants identifies four clinically distinct symptom presentations (phenotypes), adding to the growing body evidence that Long COVID is not singular condition but rather a range of conditions that may evolve, and typically improve, over time.

5 Jun 2023

International response may be inadequate to meet the scale and severity of antimicrobial resistance

Governments around the world must do more to tackle the growing threat of drug-resistant infections, new research suggests.

5 Jun 2023

Study finds surprising similarities in COVID-19 mortality rates between certain U.S. states and Canadian provinces

While the overall mortality rates - the number of deaths per 100,000 people - during the early stages of the COVID-19 pandemic were higher in the United States compared to Canada, a new study at the University of Missouri finds some surprising similarities in mortality rates between certain U.S. states and Canadian provinces.

2 Jun 2023

University of Louisville researchers receive $5.8 million to prevent immune system dysregulation

Researchers at the University of Louisville have received $5.8 million in two grants from the National Institutes of Health to expand their work to better understand and prevent immune system dysregulation responsible for acute respiratory distress, the condition responsible for serious illness and death in some COVID-19 patients.

2 Jun 2023

Scientists investigate how immune system's T cells could fight many coronaviruses at once

Scientists at La Jolla Institute for Immunology (LJI) are investigating how the immune system's T cells react to a wide variety of coronaviruses, ranging from SARS to common cold coronaviruses.

1 Jun 2023

Study measures the annual prevalence of nontuberculous mycobacterial lung disease in Ontario, Canada

Researchers determined the prevalence of nontuberculous mycobacterial pulmonary disease (NTM-PD) in 2020.

1 Jun 2023

Infectious Diseases News and Research

New cell culture model generates the alveolar macrophage in the lab

Metformin reduces risk of long COVID by over 40%

Rising alcohol consumption in China linked to increased risk of 61 diseases

Oliver Dowden: New Biothreats Radar will be key to the UK’s fight against future biological threats

Common diabetes drug prevents the development of long COVID, study finds

Higher levels of loss aversion among women linked to lower willingness to take risks than men

Study reveals factors impacting pertussis antibody half-lives in infants, sheds light on preterm infants' resilience

How did the COVID-19 pandemic impact the fungal infection hospitalization rates?

Investigating the alveolar type II reparative response in COVID-19 pneumonia

Insilico Medicine nominates pan-TEAD inhibitor as a potential solution for drug resistance in solid tumor patients

Debt deal leaves health programs (mostly) intact

University Hospital Centre for Emerging Viral Diseases named as a WHO collaborating center for epidemic and pandemic diseases

How the mixed messaging of vaccine skeptics sows seeds of doubt

Global partnership to make UQ a major international hub for vaccine discovery and development

New data from the nationwide INSPIRE study shows Long COVID is not a singular condition

International response may be inadequate to meet the scale and severity of antimicrobial resistance

Study finds surprising similarities in COVID-19 mortality rates between certain U.S. states and Canadian provinces

University of Louisville researchers receive $5.8 million to prevent immune system dysregulation

Scientists investigate how immune system's T cells could fight many coronaviruses at once

Study measures the annual prevalence of nontuberculous mycobacterial lung disease in Ontario, Canada

NGS for Infectious Disease Surveillance eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News